X-Linked Thrombocytopenia and Thrombocytopathia: Attenuated Wiskott-Aldrich Syndrome

H Stormorken; B Hellum; T Egeland; T G Abrahamsen; T Hovig

doi:10.1055/s-0038-1648139

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1991; 65(03): 300-305
DOI: 10.1055/s-0038-1648139

Original Article

Schattauer GmbH Stuttgart

X-Linked Thrombocytopenia and Thrombocytopathia: Attenuated Wiskott-Aldrich Syndrome

Functional and Morphological Studies of Platelets and Lymphocytes

Autoren

H Stormorken

¹The Coagulation Laboratory, Medical Department A, Research Institute for Internal Medicine, University of Oslo, Rikshospitalet, Oslo, Norway
B Hellum

¹The Coagulation Laboratory, Medical Department A, Research Institute for Internal Medicine, University of Oslo, Rikshospitalet, Oslo, Norway
T Egeland

²The Institute for Immunology and Rheumatology, University of Oslo, Rikshospitalet, Oslo, Norway
T G Abrahamsen

³The Department of Pediatrics, University of Oslo, Rikshospitalet, Oslo, Norway
T Hovig

⁴The Electron Microscopic Laboratory, Department of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway

Abstract

als PDF herunterladen

Summary

Detailed studies on the rare disorder X-linked thrombocytopenia showed that it resembles the Wiskott-Aldrich syndrome (WAS) in inheritance, clinical bleeding tendency, platelet morphology, marked thrombocytopenia and microplatelets. The calculated platelet mass was 5% of normal. Functional and biochemical studies indicated qualitatively normal aggregation and release mechanisms, whereas a moderate storage pool defect was present. The classical platelet membrane glycoproteins and lymphocyte sialophorin (CD 43) were normal.

The reason for the bleeding tendency was concluded to be deficient hemostatic plug formation resulting from the low platelet mass and a moderate storage pool defect.

The only clear distinction from WAS was the normal immunofunctional tests, the moderate tendency to infections and the absence of eczema. We therefore consider the trait as an attenuated form of WAS. That women are affected may indicate a particular variant.

PDF (254 kb)

Referenzen

References
1 Ormerod AD. The Wiscott-Aldrich syndrome. Int. J Dermatol 1985; 24: 77-80
2 Donnér M, Schwartz M, Carlsson KU, Holmberg L. Hereditary Xlinked thrombocytopenia maps to the same chromosomal region as the Wiscott-Aldrich syndrome. Blood 1988; 72: 1849-1853
3 Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood 1977; 50: 303
4 Parkman R, Remold-O’Donnell E, Kenney DM, Perrine S, Rosen FS. Surface protein abnormalities in lymphocytes and platelets in patients with Wiscott-Aldrich syndrome. Lancet 1981; December 19/ 26: 1387-1389
5 Remold-O’Donnell E, Zimmerman C, Kenney D, Rosen FS. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiscott-Aldrich syndrome. Blood 1987; 70: 104-109
6 Pallant A, Eskenazi A, Mattei M-G, Fournier REK, Carlsson SR, Fukuda M, Frelinger JG. Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 1989; 86: 1328-1332
7 Voss D. Untersuchungen zur Gerinnselretraktion. Proc VII Congr Int Soc Haematol, Rome 1958; 346
8 Steen VM, Holmsen H. Synergism between thrombin and epinephrine in human platelets: Different dose-response relationships for aggregation and dense granule secretion. Thromb Haemostas 1985; 54: 680-683
10 Solum NO, Olsen TM. Effects of diamide and dibucaine on platelet glycoprotein Ib, actin-binding protein and cytoskeleton. Biochim Biophys Acta 1985; 817: 249-260
10 Towbin FI, Staehelin I, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 1979 76. 4350-4354
11 Thorsen LI, Gaudernack G, Brosstad f, Pedersen TM, Solum NO. Identification of platelet antigens by monoclonal antibodies using crossed immunoelectrophoresis with immunoblotting of the monoclonal antibody. Thromb Haemostas 1987; 57: 212-216
12 Gaudernack G, Lundin KEA. Rapid immunomagnetic phenotyping of cells. J Immunogenetics 1989; 16: 169-175
13 Egeland I, Lea T. A rapid rosette technique for quantitation and separation of mononuclear cell subsets using monoclonal antibodies. J Immunol Meth 1982; 55: 213-219
14 Kleveland G, Egeland T, Lea T. Quantitation of rheumatoid factors (RF) of IgM, IgA, and IgG isotypes by a simple and Discrimination between false and true IgG-RE. Scand J Rheumatol 1988; (Suppl. 75) suppl 15-24
15 Frojmovic MM, Milton JG, Duchastel A. Microscopic measurements of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation. J Lab Clin Med 1983; 101: 964-976
16 Pidard D, Didry D, Le Deist I, Durandy A, Griscelli C, Bellucci S, Nurden AI. Analysis of the membrane glycoproteins of platelets in the Wiscott-Aldrich syndrome. Br J Haematol 1988; 69: 529-545
17 Grgttum KA, Hovig I, Holmsen Fr, Foss Abrahamsen A, Jeremic M, Seip M. Wiscott-Aldrich Syndrome: Qualitative platelet defects and short platelet survival. Br J Haematol 1969; 17: 373-346
18 Baldini MG. Nature of the platelet defect in the Wiscott-Aldrich syndrome. Ann NY Acad Sci 1972; 201: 437-444
19 Marone G, Albini R, di Martino L, Quatterin S, Poto S, Condorelli M. The Wiscott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes. Br J Haematol 1986; 62: 737-745
20 Murphy S. Hereditary thrombocytopenia. Clinics Haematol 1972; 1 (02) 359-368
21 Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiscott-Aldrich syndrome: Studies of lymphocytes, granulocytes and platelets. Blood 1980; 55: 243-251
22 Akkerman JwN, van Brederode W, Gorter G, Zegers BJM, Kuis W. The Wiscott-Aldrich syndrome: Studies on a possible defect in mitochondrial ATP resynthesis in platelets. Br J Haematol 1982; 51: 561-568